Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(94 sites)

United States

Research Site, Phoenix, Arizona

Research Site, Duarte, California

Research Site, Jacksonville, Florida

Research Site, Tampa, Florida

Research Site, Chicago, Illinois